BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32803287)

  • 1. Tacrolimus monitoring parameters are not associated with acute cellular rejection following lung transplantation.
    Kao CC; Segraves J; Parulekar AD
    Eur J Clin Pharmacol; 2021 Jan; 77(1):63-69. PubMed ID: 32803287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing tacrolimus time-in-therapeutic range is associated with superior one-year outcomes in lung transplant recipients.
    Ensor CR; Iasella CJ; Harrigan KM; Morrell MR; Moore CA; Shigemura N; Zeevi A; McDyer JF; Venkataramanan R
    Am J Transplant; 2018 Jun; 18(6):1527-1533. PubMed ID: 29513387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of aerosolized antipseudomonals on Pseudomonas positivity and bronchiolitis obliterans syndrome after lung transplantation.
    Moore CA; Pilewski JM; Venkataramanan R; Robinson KM; Morrell MR; Wisniewski SR; Zeevi A; McDyer JF; Ensor CR
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28273385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial.
    Zuckermann A; Reichenspurner H; Birsan T; Treede H; Deviatko E; Reichart B; Klepetko W
    J Thorac Cardiovasc Surg; 2003 Apr; 125(4):891-900. PubMed ID: 12698153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus Variability and Clinical Outcomes in the Early Post-lung Transplantation Period: Oral Versus Continuous Intravenous Administration.
    van Dommelen JEM; Grootjans H; Uijtendaal EV; Ruigrok D; Luijk B; van Luin M; Bult W; de Lange DW; Kusadasi N; Droogh JM; Egberts TCG; Verschuuren EAM; Sikma MA
    Clin Pharmacokinet; 2024 May; 63(5):683-693. PubMed ID: 38581638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher Risk of Acute Cellular Rejection in Lung Transplant Recipients with Cystic Fibrosis.
    Calabrese F; Lunardi F; Nannini N; Balestro E; Loy M; Marulli G; Calabrese F; Vuljan SE; Schiavon M; Perissinotto E; Rea F
    Ann Transplant; 2015 Dec; 20():769-76. PubMed ID: 26718747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher tacrolimus trough levels on days 2-5 post-renal transplant are associated with reduced rates of acute rejection.
    O'Seaghdha CM; McQuillan R; Moran AM; Lavin P; Dorman A; O'Kelly P; Mohan DM; Little P; Hickey DP; Conlon PJ
    Clin Transplant; 2009; 23(4):462-8. PubMed ID: 19681975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tacrolimus blood levels and incidence of graft rejection in heart transplantation].
    Albornoz López R; Aumente Rubio MD; Arizón Del Prado JM; Cárdenas Aranzana M; López Malo de Molina MD; Gago Sánchez AI
    Farm Hosp; 2005; 29(3):158-63. PubMed ID: 16013941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinically Significant Drug Interaction Between Clotrimazole and Tacrolimus in Pancreas Transplant Recipients and Associated Risk of Allograft Rejection.
    Viesselmann CW; Descourouez JL; Jorgenson MR; Radke NA; Odorico JS
    Pharmacotherapy; 2016 Mar; 36(3):335-41. PubMed ID: 26877191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nationwide conversion to generic tacrolimus in pediatric kidney transplant recipients.
    Naicker D; Reed PW; Ronaldson J; Kara T; Wong W; Prestidge C
    Pediatr Nephrol; 2017 Nov; 32(11):2125-2131. PubMed ID: 28660366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time to reach tacrolimus maximum blood concentration,mean residence time, and acute renal allograft rejection: an open-label, prospective, pharmacokinetic study in adult recipients.
    Kuypers DR; Vanrenterghem Y
    Clin Ther; 2004 Nov; 26(11):1834-44. PubMed ID: 15639695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Tacrolimus Trough Variability on Acute Rejection Following Lung Transplantation.
    Evans KB; Beermann KJ; Lee HJ; Harris M; Frankel CW; Berry H; Ali HA
    Transplant Proc; 2022 Oct; 54(8):2270-2276. PubMed ID: 36123193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation.
    Staatz C; Taylor P; Tett S
    Nephrol Dial Transplant; 2001 Sep; 16(9):1905-9. PubMed ID: 11522877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection.
    Yamani MH; Starling RC; Goormastic M; Van Lente F; Smedira N; McCarthy P; Young JB
    Transplantation; 2000 Jun; 69(11):2326-30. PubMed ID: 10868634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus: a further update of its use in the management of organ transplantation.
    Scott LJ; McKeage K; Keam SJ; Plosker GL
    Drugs; 2003; 63(12):1247-97. PubMed ID: 12790696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rescue alemtuzumab for refractory acute cellular rejection and bronchiolitis obliterans syndrome after lung transplantation.
    Ensor CR; Rihtarchik LC; Morrell MR; Hayanga JW; Lichvar AB; Pilewski JM; Wisniewski S; Johnson BA; D'Cunha J; Zeevi A; McDyer JF
    Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28008661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients.
    Penninga L; Penninga EI; Møller CH; Iversen M; Steinbrüchel DA; Gluud C
    Cochrane Database Syst Rev; 2013 May; (5):CD008817. PubMed ID: 23728681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yield of surveillance bronchoscopy for acute rejection and lymphocytic bronchitis/bronchiolitis after lung transplantation.
    Chakinala MM; Ritter J; Gage BF; Lynch JP; Aloush A; Patterson GA; Trulock EP
    J Heart Lung Transplant; 2004 Dec; 23(12):1396-404. PubMed ID: 15607670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
    Shenoy S; Hardinger KL; Crippin J; Korenblat K; Lisker-Melman M; Lowell JA; Chapman W
    Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of tacrolimus rescue therapy in refractory acute rejection after lung transplantation.
    Vitulo P; Oggionni T; Cascina A; Arbustini E; D'Armini AM; Rinaldi M; Meloni F; Rossi A; Viganò M
    J Heart Lung Transplant; 2002 Apr; 21(4):435-9. PubMed ID: 11927219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.